MRÁZ, Marek, Karla MALINOVÁ, Jana KOTAŠKOVÁ, Šárka PAVLOVÁ, Boris TICHÝ, Jitka MALČÍKOVÁ, Kateřina STAŇO KOZUBÍK, Jana ŠMARDOVÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Martin TRBUŠEK, Jiří MAYER and Šárka POSPÍŠILOVÁ. miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities. Leukemia. 2009, vol. 23, No 1, p. 1159-63, 5 pp. ISSN 0887-6924.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities.
Name in Czech miR-34a, miR-34a, miR-29c a miR-17-5p jsou snizene exprimovany u CLL pacientů s abnormalitami TP53
Authors MRÁZ, Marek, Karla MALINOVÁ, Jana KOTAŠKOVÁ, Šárka PAVLOVÁ, Boris TICHÝ, Jitka MALČÍKOVÁ, Kateřina STAŇO KOZUBÍK, Jana ŠMARDOVÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Martin TRBUŠEK, Jiří MAYER and Šárka POSPÍŠILOVÁ.
Edition Leukemia, 2009, 0887-6924.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 8.296
Organization unit Faculty of Medicine
UT WoS 000266820700018
Keywords (in Czech) charakterizace CLL; abnormality TP53
Keywords in English characterization of CLL; TP53 abnormalities
Tags International impact, Reviewed
Changed by Changed by: Mgr. Karla Plevová, Ph.D., učo 106100. Changed: 22/7/2010 11:04.
Abstract
Without abstract Without abstract Without abstract Without abstract Without abstract Without abstract Without abstract Without abstract Without abstract Without abstract
Abstract (in Czech)
Bez abstraktu Bez abstraktu Bez abstraktu Bez abstraktu Bez abstraktu Bez abstraktu Bez abstraktu Bez abstraktu Bez abstraktu
Links
NR9293, research and development projectName: Využití mikroRNA a malých interferujících RNA v diagnostice a léčbě leukémií
PrintDisplayed: 26/7/2024 05:21